Portugal reminds supply chain of product information obligations
This article was originally published in Clinica
Portugal’s regulatory agency Infarmed has issued to all parties involved in supplying the country with healthcare products a formal reminder about the various documents they are obliged to hold so as to ensure they know what the devices do and can guarantee their quality and safety.
You may also be interested in...
Companion diagnostics are needed increasingly by pharma companies to justify the safety and effectiveness of their products. With specific first-time EU regulation of these products within sight – and urgently needed – is there a risk of delays to these products being able to demonstrate compliance?
Draft policy moots crowdfunding for high-cost rare diseases alongside financial support for those "amenable to one-time treatment" but falls way short of some patient groups' expectations.
India’s Hilleman Laboratories says it’s aiming to develop an affordable vaccine that will target pregnant women in low- and middle-income countries to prevent Group B Streptococcus, a potentially fatal infection passed to babies during childbirth.